IRIS
ARAGONA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 223
EU - Europa 136
AS - Asia 100
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 461
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 222
CN - Cina 69
IE - Irlanda 47
SE - Svezia 46
IT - Italia 27
SG - Singapore 11
IN - India 9
TR - Turchia 8
DE - Germania 4
FI - Finlandia 4
AT - Austria 2
CZ - Repubblica Ceca 2
IR - Iran 2
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
EU - Europa 1
GB - Regno Unito 1
IL - Israele 1
NL - Olanda 1
PA - Panama 1
Totale 461
Salva come PNG Salva come JPEG
Città #
Chandler 80
Dublin 47
Ashburn 35
Shanghai 18
Beijing 15
Nanjing 12
Izmir 7
Princeton 7
Singapore 7
New York 6
Pune 6
Wilmington 5
Ann Arbor 4
Bremen 4
Dearborn 4
Helsinki 4
Parma 4
San Mateo 4
Calenzano 3
Changsha 3
Marnate 3
Mumbai 3
Ningbo 3
Norwalk 3
Boardman 2
Bologna 2
Cremona 2
Kunming 2
Nanchang 2
Shenyang 2
Tianjin 2
Vienna 2
Abidjan 1
Amsterdam 1
Andover 1
Atlanta 1
Borgia 1
Brussels 1
Chengdu 1
Des Moines 1
Hebei 1
Hefei 1
Jiaxing 1
Kocaeli 1
Leawood 1
Los Angeles 1
Neviano degli Arduini 1
Panama City 1
Prague 1
Rome 1
Seattle 1
Sofia 1
Tappahannock 1
Tel Aviv 1
Venice 1
Totale 326
Salva come PNG Salva come JPEG
Nome #
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 62
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 59
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 55
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: Results from a large Italian cohort study 54
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 52
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 46
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 38
The management of endoscopic retrograde cholangiopancreatography- related infections risk: results of an italian survey at regional level 30
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 27
Spyglass percutaneous transhepatic lithotripsy of symptomatic recurrent lithiasis of the intrahepatic bile duct with distal stenosis 18
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 16
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 14
Totale 471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 17 5 0 0 0 3 4 1 0 8 0 0
2020/202115 0 0 0 0 0 0 0 0 8 5 1 1
2021/202244 1 1 0 1 4 0 5 0 4 3 5 20
2022/2023219 14 24 18 23 12 27 1 20 68 5 6 1
2023/2024118 6 10 8 5 10 19 11 23 2 6 8 10
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 471